We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 90-year-old woman was referred by her ophthalmologist ...
Findings from THRIVE showed treatment with veligrotug led to statistically significant improvements in the signs and symptoms of TED. Topline data were announced from a phase 3 study evaluating ...
A 14-year-old otherwise healthy girl developed right eye pain in the periorbital area and proptosis of sudden onset. She was being followed because of mild proptosis. However, the eyelid swelling ...
Please provide your email address to receive an email when new articles are posted on . Teprotumumab reduces proptosis by 2 mm or more for most adults with long-standing thyroid eye disease and low ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian Therapeutics announced positive long-term durability data from its Phase 3 ...
Everyday Health on MSN
How to manage 6 common challenges of living with thyroid eye disease
What to know about medical treatments, lifestyle adjustments, and more to navigate life with TED.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results